tiprankstipranks
Trending News
More News >
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
US Market

Virax Biolabs Group Ltd. Class A (VRAX) Stock Investors

Compare
104 Followers
Based on 800,570 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold VRAX
On average, investors allocate 0.00% of their portfolios to VRAX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 800,570 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding VRAX

1.3%
Last 7
Days
9.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding VRAX, out of 800,570 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

VRAX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of investors who made their portfolios public
The table shows changes in VRAX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

VRAX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Lucid Group
5.34%
+0.30%
-1.50%
7.81B
Consumer Cyclical
Marathon Digital Holdings
4.95%
-1.95%
-3.77%
5.51B
Financial
Riot Platforms
4.49%
-1.80%
-1.93%
3.05B
Financial
Nio
8.35%
-0.65%
-4.55%
8.12B
Consumer Cyclical
Recursion Pharmaceuticals
3.16%
-0.98%
-6.63%
1.68B
Healthcare
Viking Therapeutics
3.75%
-0.49%
-4.75%
3.11B
Healthcare
AST SpaceMobile
5.55%
+0.96%
+0.33%
8.01B
Technology
BigBearai Holdings
4.14%
-1.14%
-0.86%
1.06B
Technology
Oneok
4.47%
-1.00%
-4.93%
50.68B
Energy
Applied Digital Corporation
4.29%
+0.45%
-0.33%
1.68B
Financial
Based on the activity of 800,570 active portfolios
Open your Smart Portfolio

VRAX Investor Analysis

VRAX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
14.3%
of VRAX holders
are under 35
Average Segment Performance
Average P/E Ratio11.76
Beta4.25
Dividend Yield4.06%
VRAX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
42.9%
of VRAX holders
are between 35–55
Average Segment Performance
Average P/E Ratio6.19
Beta11.21
Dividend Yield3.42%
VRAX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
42.9%
of VRAX holders
are over 55
Average Segment Performance
Average P/E Ratio1.75
Beta6.30
Dividend Yield3.69%
Overview of age group and performance of VRAX stock investors
See who invests in VRAX according to age group and performance.

FAQ

How many retail Investors hold VRAX?
<0.1% of TipRanks' retail investors hold VRAX in their portfolios.
    What is VRAX Investor Sentiment?
    VRAX’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of VRAX in the last 7 days?
      ▼ 1.3% of TipRanks' retail investors changed their holding of VRAX in the last 7 days.
        What percentage of retail investors changed their holding of VRAX in the last 30 days?
        ▼ 9.1% of TipRanks' retail investors changed their holding of VRAX in the last 30 days.
          What is the average age of retail investors who hold VRAX?
          The average age of VRAX Holders is over 55.
            What other stocks have VRAX investors also bought?
            VRAX Investors also bought LCID, MARA, RIOT, NIO, RXRX, VKTX, ASTS, BBAI, OKE, APLD.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis